Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05350553 · ClinicalTrials.gov registry record
Methylglyoxal Evaluation in Humans
A clinical trial of Type 2 Diabetes and Chronic Low Back Pain, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- 39
- Enrollment target
- 1
- Study location
NCT05350553 is a study of Type 2 Diabetes and Chronic Low Back Pain that has completed, run by University of Kansas Medical Center. The registered enrollment target is 39 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05350553, a study of Type 2 Diabetes and Chronic Low Back Pain, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will test the hypothesis that patients with low back pain associated with lumbar disc aberrancy will have elevated MGO-protein levels circulating in the blood that are comparable to patients with painful diabetic neuropathy.
Conditions Studied
Study Locations (1)
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2022-05-02 |
| Est. Completion | 2025-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05350553
The ClinicalTrials.gov registry entry for NCT05350553 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (96% lower). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 0 interventions.
NCT05350553 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.
Frequently Asked Questions
What is clinical trial NCT05350553 about?
NCT05350553 is a clinical study titled "Methylglyoxal Evaluation in Humans". The investigators will test the hypothesis that patients with low back pain associated with lumbar disc aberrancy will have elevated MGO-protein levels circulating in the blood that are comparable to patients with painful diabetic neuropathy.
What is the current status of trial NCT05350553?
This trial is currently completed. The enrollment target is 39 participants. The study started on 2022-05-02. Estimated completion is 2025-04-01.
What conditions does trial NCT05350553 study?
This clinical trial studies the following conditions: Type 2 Diabetes, Chronic Low Back Pain, Lumbar Disc Herniation, Neuropathy, Painful.
Who is sponsoring clinical trial NCT05350553?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05350553 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
Mechanism of SGLT2 Inhibition in the Kidney
RECRUITING · Phase 4
-
Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.